H.I.G.-backed Vernacare buys Bailey and ASep in buy-and-build push
What's the deal? VernacareDealroom has a profile for this one. Try Dealroom →, a UK-based manufacturer of medical consumables backed by H.I.G. Capital, has acquired podiatry-instrument maker Bailey InstrumentsDealroom has a profile for this one. Try Dealroom → and tourniquet supplier ASep HealthcareDealroom has a profile for this one. Try Dealroom →. Terms were not disclosed. The two deals add brands in podiatry, blood collection, and infection prevention to Vernacare's portfolio.
What each company does: Bailey, founded in 1989, makes specialist podiatry instruments and distributes to more than 30 countries. ASep supplies single-use and reusable tourniquets for blood collection, phlebotomy, and venous access, with an international customer base.
What's the endgame? Vernacare says the acquisitions strengthen its reach across acute hospital, community, and specialist care. It plans to sell Bailey's podiatry products and ASep's tourniquets to new customers and markets through its own commercial network.
Why now? The deals are Vernacare's fifth and sixth acquisitions since H.I.G. invested in 2020, following the April 2026 purchase of Eakin SurgicalDealroom has a profile for this one. Try Dealroom →. "These acquisitions reflect our strategy of investing in differentiated medical products," said chief executive officer Alex Hodges.
The signal: This is continued execution of a buy-and-build plan, not a transformational deal. It fits a wider pattern of UK medical-products companies using acquisitions to add complementary products and scale.
Read more: clinicalservicesjournal.com
Image credit: Generated with Gemini
